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Abstract
Background:  Abnormal collagen metabolism is thought to play an important role in the
development of primary inguinal hernia. This is underlined by detection of altered collagen
metabolism and structural changes of the tissue in patients with primary inguinal hernia. However,
it is still unknown whether these alterations reflect a basic dysfunction of the collagen synthesis, or
of collagen degradation.
Methods: In the present study, we analysed type I and type III procollagen messenger ribonucleic
acid (mRNA) and MMP-1 and MMP-13 mRNA in cultured fibroblasts from the skin of patients with
primary inguinal hernia, and from patients without hernia (controls) by reverse transcription
polymerase chain reaction (RT-PCR) and Northern Blot.
Results: The results indicated that the ratio of type I to type III procollagen mRNA was decreased
in patients with primary hernia, showing significant differences as compared to controls (p = 0.01).
This decrease was mainly due to the increase of type III procollagen mRNA. Furthermore, RT-PCR
analysis revealed that the expression of MMP-1 mRNA in patients with primary hernia is equivalent
to that of controls (p > 0.05). In addition, MMP-13 mRNA is expressed neither in patients with
primary hernia nor in controls.
Conclusion:  We concluded that abnormal change of type I and type III collagen mRNAs
contribute to the development of primary inguinal hernia, whereas the expressions of MMP-1 and
MMP-13 mRNA appears not to be involved in the development of primary inguinal hernia. Thus,
the knowledge on the transcriptional regulation of collagen in patients with primary inguinal hernia
may help to understand the pathogenesis of primary inguinal hernia, and implies new therapeutic
strategies for this disease.
Background
Several connective tissue diseases have been related to an
abnormal collagen metabolism. Although for the devel-
opment of an abdominal wall hernia evident molecular-
biological links are missing. A disease of the soft tissues
has been accused to be a decisive factor. Correspondingly,
the patients with an aortic abdominal aneurysm [1,2],
with an Ehlers-Danlos syndrome [3] or with a poly cystic
kidney disease [4] show an increased risk for inguinal her-
niation. Furthermore, previous studies on protein level in-
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dicate that patients with an inguinal hernia present a
disturbed collagen proportion with a reduced ratio of type
I and type III collagen as well as abnormal ultra-structural
changes of the deposited collagen [5–7]. Friedman et al.
showed increases in type III collagen gene expression and
protein synthesis in patients with inguinal hernias [6]. A
defective collagen metabolism contributes to a decreased
tensile strength and mechanical stability of both the con-
nective tissues and the induced scar tissue [8–11]. There-
fore these alterations in collagen formation should be of
central relevance in the pathophysiology of hernias.
The altered ratio of the collagen subtypes can result either
by a modified synthesis or by an imbalanced breakdown.
The cleavage is regulated by the activity of the matrix met-
allo-proteinases (MMPs), proteins of a family of zinc-de-
pendent endopeptidases. Among them MMP-1 and MMP-
13 are the principal matrix enzymes cleaving fibrillar type
I, II and III collagen [12–14]. It has been shown that these
MMPs can play a pathologic role in excessive breakdown
of some connective tissue components, e.g. in rheumatoid
arthritis [15], osteoarthritis [16], in atherosclerosis, in tu-
mor cell invasion and metastasis [12,17]. In particular,
the alterations in MMP-1 and MMP-13 protein expres-
sions could have been responsible for the changed ratio of
type I to type III collagen on the protein level. Neverthe-
less, as firstly shown in investigations by Bellon et al. in
1997, cultured fibroblasts in fascia transversalis from pa-
tients with inguinal hernia showed no differences in the
expression of matrix metallo-proteinase-1, whereas the
same author later detected a MMP-2 overexpression in
these patients [18,19].
In our own previous studies, we determined collagen type
I and type III in the skin of patients with indirect and di-
rect inguinal hernia both by immunohistochemistry and
Western blot analysis and quantified the immunhisto-
chemical expression of MMP-1 and MMP-13. The results
indicated that the ratio of collagen type I/III was signifi-
cantly decreased in the skin of patients with either indirect
or direct inguinal hernia, with a concomitant increase in
collagen type III (p < 0,001 vs. control). Likewise the re-
sults of Bellon et al., we found no significant differences
in the expression of MMP-1. No MMP-13 was detected in
any of the skin samples investigated [20].
In the present study we examined cultured fibroblasts
from the skin of patients with primary inguinal hernia
and analysed the mRNA expressions of types I and III col-
lagen to verify the up- or downregulation of the collagen
synthesis. In addition to that, MMP-1- and MMP-13-
mRNA were analysed in order to confirm the previous re-
sults on protein level that these components of the de-
grading system are not involved in the pathogenesis of
herniation.
The confirmation of a fibroblast malfunction should give
strong evidence of a systemic or genetic connective tissue
disease of patients with an inguinal hernia.
Materials and methods
Patients, tissue samples and fibroblast cultures
A total of 10 patients participated in this study of the De-
partment of Surgery. Informed consent was obtained from
all patients. Skin tissue samples were taken from patients
with primary inguinal hernia during the operation (n = 5,
mean age 58 years, range 50–72 years) and from a group
of patients undergoing interventions for intra-abdominal
inflammatory diseases without any pre-existing scar and
clinical signs of herniation (control, n = 5, mean age 61
years, range 52–70 years). Patients with steroid therapy,
previous history of any abdominal surgery, diabetes, ab-
dominal aortic aneurysm and connective tissue diseases
were excluded from the study.
All skin specimens were obtained under strictly sterile
conditions and transfered to a fibroblast culture system as
previously described [21].
Extraction of total RNA
The chemicals and reagents used for extraction of total
RNA and RT-PCR were purchased from Promega (Prome-
ga, USA) unless otherwise stated. Total RNA was extracted
from confluent fibroblast cultures. About 5 ×  106 cells
were homogenised in 600 µl ice cold denaturing solution,
60 µl 2 M sodium acetate, pH 7.4 and 600 µl phenol: chlo-
roform :isoamyl alcohol (125:24:1), pH 4.7. The superna-
tant then was collected at 12000 revolutions per minute
and the remaining phenol was removed after adding chlo-
roform to the aqueous phase. Afterwards, the total RNA
was precipitated with an equal volume of ice cold isopro-
panol at -20°C overnight. The pellet was washed in 70%
ethanol (-20°C) and resuspended in RNase-free water.
The concentration, purity and integrity of total RNA were
determined by GeneQuant II (Pharmacia Biotech, Eng-
land) and visualised electrophoretically by separation in a
denaturing agarose gel (1%) containing ethidium bro-
mide. Total RNA used for RT-PCR was treated with RQ1
RNase-free DNase (1µ/µg total RNA) at 37°C for 30 min-
utes prior to RT-PCR. Then phenol: chloroform :isoamyl
alcohol was added and the total RNA was participated
with iso-propanol to remove DNase as described above.
RT-PCR
Oligonucleotide primers were designed using the pub-
lished sequences of type collagen I and III genes [22],
MMP-1 and MMP-13 genes [13], and β -actin gene. They
were synthesised by Genset (Genset, France). Table 1 lists
the primers employed in the present experiment.BMC Medical Genetics 2002, 3 http://www.biomedcentral.com/1471-2350/3/2
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Synthesis of cDNA was carried out at 42°C for 55 minutes
in 20 µl final volume containing 1 µg total RNA, 5 mM
MgCl, 1 ×  reverse transcription buffer, 1 mM each dNTP,
1 U/µl recombinant RNasin® ribonuclease inhibitor, 15
U/µg (total RNA) AMV reverse transcriptase and 0.5 µg ol-
igo(dT)15 primer. Afterwards, 2 µl of cDNA was added to
the PCR reaction. The PCR reaction volume of 50 µl con-
sisted of 1.5 mM MgCl2, 1 ×  thermophilic DNA polymer-
ase reaction buffer (MgCl2-free), 200 µM each dNTP, 1.25
U taq DNA polymerase. The optimal concentration of
primers used was 5 pmol for β -actin, 50 pmol for type I
and III collagen, MMP-1 and MMP-13. PCR amplification
was performed for 30–40 cycles with denaturation at
95°C for 60 seconds, annealing at the indicated tempera-
ture (Table 1), each for 60 seconds, and extention at 72°C
for 90 seconds. PCR was repeated thrice with each sample.
PCR products were electrophoretically fractionated on a
1.2–1.8% agarose gel containing ethidium bromide.
Semiquantitative determination was performed densito-
metrically using the Multi-Analyst from Biorad (Biorad,
USA). The size and intensity of each band was assessed
and the results were integrated as follows: relative amount
of PCR products = band area ×  band specific intensity. All
values were corrected by β -actin mRNA levels as an inter-
nal standard.
Northern Blot
The chemicals and reagents used for Northern Blot were
purchased from Boehringer Mannheim (Germany) unless
otherwise stated. Total RNA, 18 µg/lane, was fractionated
on 1% agarose gel containing 2.2 M formaldehyde. The
RNA was transferred to a charged nylon membrane by
capillary method overnight in 20 ×  SSC transfer buffer at
room temperature and fixed by baking at 120°C for 30
minutes. Prehybridisation and hybridisation were per-
formed at 10°C below the evaluated melting temperature
of oligonucleotides in Dig Easy Hyb. The specific internal
oligonucleotides used in the present study can be hybrid-
ised to unique sequences within type I collagen (5'-AAC-
CTCAAGAAGGCCCTGCT-3', melting temperature 62°C)
[23], type III collagen (5'-AGAAACTGCAGACCTGAA-3',
melting temperature 58°C) [24] and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH, 5'-ATGACATCAA-
GAA-GGTGGTGAA-3', melting temperature 51°C) [13]
respectively. These three oligonucleotide probes, and their
respective anti-sense probes were synthesised (Genset,
France) and, afterwards, were 3' end-labelled with digoxi-
genin-11-dUTP using terminal transferase at 37°C for 15
minutes (10 pmol/ml). The sense oligonucleotide probes
served as negative controls, whereas the anti-sense oligo-
nucleotide probe were used for the investigation of type I
collagen mRNA, type III collagen mRNA and GAPDH mR-
NA, respectively.
After stringent washes, the membrane was blocked by in-
cubation with 1% blocking reagent for 1 hour at room
temperature. A 1:20000 dilution of anti-Dig-alkaline
phosphatase was incubated with the membrane for 30
minutes at room temperature. Finally, hybridization
products were exposed to chemoluminescent detection
film for up to 10 minutes.
The relative amount of type I and type III collagen mRNA
were determined densitometrically using the Multi-Ana-
lyst from Biorad (Biorad, USA) after standardisation of
both type I and type III collagen mRNA levels with their
respective GAPDH mRNA levels.
Statistical Methods
Statistical analysis was carried out using Statistical Pack-
age for Social Sciences (SPSS) – software. Student's two-
tail t-test was used to determine statistically the differenc-
es between controls and primary hernias. All data were
presented as mean ± SD (standard deviation). Values of p
< 0.05 were considered to be statistically significant.
Table 1: Primer sets used for RT-PCR
mRNA template Primer sequence (sense/anti-sense) PCR product size (bp) Annealing temperature
type I collagen 5'CCCCCTCCCCAGCCACAAAG-3' 5'-
TCTTGGTCGGTGGGTGACTCT-3'
360 44°C
type III collagen 5'-CCAAACTCTATCTGAA-3' 5'-GGACT-
CATAGAATACA-3'
449 44°C
MMP-1 5'-AGGTTATCCCAAAATGATAG-3' 5'-
TGCAGTTGAACCAGCTATTA-3'
173 55°C
MMP-13 5'-TTCTGGCACATGCTTTTCCTC-3' 5'-
GGTTGGGGTCTTCATCTCCTG-3'
273 55°C
β -actin 5'-ATCTGGCACCACACTTCTACA-3' 5'-
GTTTCGTGGATGCCACAGGACT-3'
577 55°CBMC Medical Genetics 2002, 3 http://www.biomedcentral.com/1471-2350/3/2
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Results
Expression of collagen type I and type III
The product size and intensities for each of the amplified
products by using RT-PCR are shown in figure 1. The am-
plified product size for each are 577 bp for β -actin, 360 bp
for type I collagen, and 449 bp for type III collagen. The
respective intensities of β -actin are almost equivalent in
the same PCR reaction. The densitometric analysis
showed the variation between lanes to be less than 10%,
both for each individual experiment and between experi-
ments. Semiquantitative analysis of PCR products showed
that the densitometry units of type I and type III collagen
were 0.46 ± 0.06 and 0.51 ± 0.07 in controls, respectively;
0.51 ± 0.06 and 0.87 ± 0.10 in patients with primary her-
nia, respectively (all values were derived after standardiza-
tion of their mRNA levels with the respective β -actin
mRNA levels). Due to the apparent increase in type III col-
lagen mRNA levels in patients with primary inguinal her-
nia the ratio of type I to type III collagen mRNA levels in
these patients were markedly reduced and showed highly
significant differences compared to the controls (0.59 ±
0.06 versus 0.90 ± 0.08; p < 0.01).
In the Northern Blot analysis the corresponding expres-
sions of type I and type III collagen mRNA in total RNA
are shown in figure 2. Semi-quantitative analysis revealed
that the relative amount of type I collagen mRNA and type
III collagen mRNA was 1.9 ± 0.2 and 1.7 ± 0.2 in controls,
respectively; 1.8 ± 0.2 and 2.2 ± 0.2 in patients with pri-
mary hernia, respectively (all values were derived after
standardisation of their mRNA levels with the respective
GAPDH mRNA levels). As a consequence of the signifi-
cant increase of type III collagen mRNA in patients with
primary hernia the ratio of type I to type III collagen
mRNA levels (0.83 ± 0.09) was apparently decreased and
showed a highly significant difference in comparison with
the ratio of controls (1.12± 0.13; p < 0.01).
Expression of MMP-1 and MMP-13
The amplified product size is 173 bp for MMP-1 by using
RT-PCR (table 1; Fig. 3). Although the expression of MMP-
1 PCR products were observed in all samples, their inten-
sities in patients with primary hernia were almost equiva-
lent to that of controls . The semiquantitative analysis
confirmed this finding, i. e. the expression of MMP-1
mRNA in patients with primary inguinal hernia did not
show any significant difference as compared to that of
controls (0.40 ± 0.04 versus 0.41 ± 0.04; p > 0.05) (all val-
ues were derived after standardisation of their mRNA lev-
els with the respective β -actin mRNA levels).
However, in contrast to the expression of MMP-1, an ex-
pression of MMP-13 PCR products was detected neither in
the patients with primary hernia nor in the controls (data
not shown), even using amplified reactions of 40 cycles.
Discussion
Abdominal wall stability depends on the integrity of the
muscular and fascial framework. The mechanical proper-
ties of each fascia relies on the connective tissue and its
Figure 1
PCR products analysis of type I and type III collagen samples
and β -actin optimisation. 1, 2 and 3) controls; 4, 5 and 6)
inguinal hernias; 7) standard marker, a) β -actin amplification
with annealing temperature at 60°C of type I collagen; b) β -
actin amplification with annealing temperature at 44°C of
type III collagen; c) type I collagen; d) type III collagen
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collagens. The predominant collagen type in skin is the
mature and mechanically stable type I collagen, whereas
the immature and instable type III collagen is typically
seen during the early phases of wound healing [25]. Thus,
in normal skin type I and III collagen are known to exist
in a ratio of up to 4:1 [26]. Earlier observations confirmed
a correlation between collagen production and their cellu-
lar mRNA levels in cells and tissues [10,11,27].
In a previous study, immunhistochemical and Western
blot analysis indicated that the ratio of collagen type I/III
was significantly decreased in the skin of patients with in-
cisional and with either indirect or direct inguinal hernia,
with a concomitant increase in collagen type III [20,21].
These findings correspond to the results of the present
study. Both RT-PCR and Northern Blot analysis revealed
that the ratio of type I to type III collagen mRNA in fibrob-
last cultures from skin of patients with primary inguinal
hernia was markedly reduced compared to normal con-
trols. The decrease is caused by a significantly increased
expression of type III collagen mRNA, whereas type I col-
lagen mRNA level was unchanged or only slightly elevat-
ed. Furthermore, these data confirmed the results of
Friedman et al. in 1993 describing a rise in the levels of
type III collagen mRNA and in type III collagen protein in
patients with primary inguinal hernia [6]. Accordingly, in
1992 Ajabnoor et al. detected in-vitro a reduced 14C-pro-
line uptake in muscle cells of patients with an inguinal
hernia [5]. The detection of a lowered ratio of type I to
type III collagen in cultured fibroblasts disproves the sup-
position that this collagen disproportion is only a second-
ary consequence to the mechanical strain or other local
influences. The detection of an impaired collagen balance
both in the tissue as well as in cultured fibroblasts under-
lines the suspicion that the development of an inguinal
hernia is likely to be implemented by a primarily distur-
bance of the fibroblast function and their collagen genes.
Based on these results we assume that the altered collagen
synthesis in hernia patients can be regarded as basic genet-
ically caused disregulation serving as an initiating or pro-
moting factor for the development of primary inguinal
hernias.
Furthermore, MMP-1 and MMP-13 were assessed as the
principal enzymes cleaving fibrillar type I, II and III colla-
gen [12–14]. Their activities are predominantly responsi-
ble for the content and proportion of type I and III
collagens. In this study, our results revealed that the ex-
pression of MMP-1 mRNA in fibroblasts from the skin did
not show any significant differences between the patients
with primary hernias and the controls. In contrast, MMP-
13 gene expression was not detected at all, neither in the
fibroblasts from the skin of patients with primary inguinal
hernias nor in the controls. This is in accordance with pre-
vious observation at the protein level [21], in which we
found a similar immuno staining reaction and intensity
against MMP-1 in the skin of primary hernia patients as
compared to controls. Furthermore, no MMP-13 protein
expression was observed by immunohistochemistry, nei-
ther in the samples of primary hernia patients nor in the
controls.
Ajabnoor et al. [5] investigated the susceptibility of the fi-
broblast extracellular matrix to degradation by colla-
genase and found no difference in collagenase activity
between inguinal hernia patients and controls. Interest-
ingly, recent investigations by Bellon et al. showed signif-
icant active MMP-2 expression by cultured fibroblasts
from the fascia transversalis of patients with inguinal her-
nias, herby confirming previous in vivo results with im-
munosorbent assay, immunoblotting and zymography
[18,19]. These results on protein level appear to suggest
that in comparison to MMP-1 and MMP-13, MMP-2 is an
active part of degradation sytem of the extracellular matrix
in hernia patients. If this enhanced MMP-2 activity is reg-
ulated through a direct increase of MMP-2 mRNA or the
answer of mediating factors of the extracellular matrix
must be investigated in further studies.
Our data confirm that patients with primary inguinal her-
nia display an increase of type III collagen mRNA in fi-
broblasts, which leads to a decreased ratio of type I to type
III collagen mRNA. The amount of MMP-1 and MMP-13
mRNA in patients with primary inguinal hernias is not
significantly different from that of the controls. The data
give strong evidence of a disorder of the collagen tissues in
patients with a primary inguinal hernia. Furthermore, the
presence of a basic impairment of the soft tissue explains
the frequently seen appearance of multiple hernias as well
as the high rate of recurrences after suture repair of about
10 % to 15%, being almost constant in many countries
[28]. As a consequence, a reinforcement of the surgical re-
pair, e.g. with alloplastic material, seems to be imperative,
at least for some patients. Larger studies are necessary to
define the proportion of patients who suffer from this col-
Figure 3
PCR products analysis of MMP-1 samples. 1, 2 and 3) con-
trols; 4, 5 and 6) primary hernias; 7) standard marker.
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lagen imbalance. A better determination of the transcrip-
tional control of collagens in various populations with
and without hernia should help to understand the patho-
physiology and the genetic background of the develop-
ment of primary inguinal hernia and to select the patients
at risk, who probably profit from surgical repair with pros-
thetic material.
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